Gilead Sciences Inc have entered into non-exclusive licensing agreements with pharma firms including three domestic majors Cipla, Jubilant Life Sciences and Hetero for manufacture and distribution of remdesivir

According to the guidance issued on Wednesday, the ICMR stated these tests can be done on blood/serum/plasma samples, the results of which are available within 30 minutes and the test comes positive after 7-10 days of infection

While the legality of the issue will get sorted out in the coming days, one thing is certain that the scramble for a share in the thriving business of rapid diagnostic kit supplies for COVID-19 is leaving several grey areas for potential legal tussles

To further India's self-reliance in testing, Mylab Solutions collaborates with Syngene International for Make in India raw materials, the company tweeted

The test called Chitra GeneLAMP-N uses the reverse transcriptase loop-mediated amplification of viral nucleic acid (RT-LAMP) for testing

Sensex, Nifty Live News Today: Top gainers on NSE Nifty and BSE Sensex included Axis Bank, ICICI Bank, HDFC, IndusInd Bank and Bajaj Finance each rising over 5%.

Stocks to watch today on April 18: TCS, Emami, United Spirits, Cadila Healthcare and more among others are the top stocks to watch out for in Friday's trading session

Catch top stories from the world of business and economy with BusinessToday.In's Biz EOD report

Mylab is the first Indian company to get commercial approval for its testing kits named as Mylab PathoDetect COVID-19 Qualitative PCR kit; the testing kit is approved by Indian FDA/CDSCO and ICMR evaluation

FMCG companies such as Nestle, HUL, ITC, P&G, Godrej Consumer, Dabur, Amul and others are set to gain ground amid sudden rise in demand due to anxiety buying and hoarding of daily essentials

Test detects genetic signature of SARS-CoV-2 virus, also known as novel coronavirus or COVID-19, in swab samples that healthcare providers collect from back of patient's throat or nose

Coronavirus India latest updates: Prime Minister Narendra Modi said on Tuesday that the nationwide lockdown will be in effect from midnight to save every Indian. The 21-day lockdown period is to prevent the further spread of COVID-19

So far the Indian government has been sourcing millions of testing kits from Germany to facilitate testing to diagnose Coronavirus patients PAN-India

According to the report 'India: the emerging hub for biologics and biosimilars', the Indian pharmaceutical companies have launched 123 biosimilars and currently have 201 active biosimilars covering multiple indications in the development pipeline

Trader groups have protested for years against e-pharmacies, saying they challenge their businesses and could allow medicines to be abused by being sold without proper verification

Diagnostic imaging sector, largely dominated by big players, constitutes 36 per cent of the market, consumables and patient aids could be another 28 per cent, Invest India estimates

With more than 75 days have passed, the Union Health Ministry has swung into action wanting to implement the ban on the manufacture, sale, distribution and import of Electronic Nicotine Delivery Systems (ENDS)